Elongation of fatty acids protein, responsible for very long carbon chain llipid biosynthesis (conserved in Eukaryota).. This group of enzymes has expanded heavily in kinetoplastids.. Localization: ER (by homology)
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 48 |
| NetGPI | no | yes: 0, no: 48 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 44 |
| GO:0110165 | cellular anatomical entity | 1 | 46 |
| GO:0005737 | cytoplasm | 2 | 2 |
Related structures:
AlphaFold database: E8NHR1
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006082 | organic acid metabolic process | 3 | 49 |
| GO:0006629 | lipid metabolic process | 3 | 49 |
| GO:0006631 | fatty acid metabolic process | 4 | 49 |
| GO:0006633 | fatty acid biosynthetic process | 5 | 49 |
| GO:0008152 | metabolic process | 1 | 49 |
| GO:0008610 | lipid biosynthetic process | 4 | 49 |
| GO:0009058 | biosynthetic process | 2 | 49 |
| GO:0009987 | cellular process | 1 | 49 |
| GO:0016053 | organic acid biosynthetic process | 4 | 49 |
| GO:0019752 | carboxylic acid metabolic process | 5 | 49 |
| GO:0032787 | monocarboxylic acid metabolic process | 6 | 49 |
| GO:0043436 | oxoacid metabolic process | 4 | 49 |
| GO:0044237 | cellular metabolic process | 2 | 49 |
| GO:0044238 | primary metabolic process | 2 | 49 |
| GO:0044249 | cellular biosynthetic process | 3 | 49 |
| GO:0044255 | cellular lipid metabolic process | 3 | 49 |
| GO:0044281 | small molecule metabolic process | 2 | 49 |
| GO:0044283 | small molecule biosynthetic process | 3 | 49 |
| GO:0046394 | carboxylic acid biosynthetic process | 5 | 49 |
| GO:0071704 | organic substance metabolic process | 2 | 49 |
| GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 49 |
| GO:1901576 | organic substance biosynthetic process | 3 | 49 |
| GO:0000038 | very long-chain fatty acid metabolic process | 5 | 5 |
| GO:0006643 | membrane lipid metabolic process | 4 | 5 |
| GO:0006665 | sphingolipid metabolic process | 4 | 5 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 5 |
| GO:0019367 | fatty acid elongation, saturated fatty acid | 7 | 5 |
| GO:0019368 | fatty acid elongation, unsaturated fatty acid | 7 | 5 |
| GO:0030148 | sphingolipid biosynthetic process | 5 | 5 |
| GO:0030497 | fatty acid elongation | 6 | 5 |
| GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 8 | 5 |
| GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 8 | 5 |
| GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 5 |
| GO:0046467 | membrane lipid biosynthetic process | 4 | 5 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 5 |
| GO:1901566 | organonitrogen compound biosynthetic process | 4 | 5 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 49 |
| GO:0004312 | fatty acid synthase activity | 5 | 49 |
| GO:0009922 | fatty acid elongase activity | 6 | 49 |
| GO:0016740 | transferase activity | 2 | 49 |
| GO:0016746 | acyltransferase activity | 3 | 49 |
| GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 49 |
| GO:0102756 | very-long-chain 3-ketoacyl-CoA synthase activity | 5 | 49 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.270 |
| CLV_NRD_NRD_1 | 238 | 240 | PF00675 | 0.469 |
| CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.336 |
| CLV_PCSK_KEX2_1 | 228 | 230 | PF00082 | 0.274 |
| CLV_PCSK_PC1ET2_1 | 228 | 230 | PF00082 | 0.278 |
| CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.582 |
| DEG_Nend_Nbox_1 | 1 | 2 | PF02207 | 0.301 |
| DOC_CKS1_1 | 40 | 45 | PF01111 | 0.438 |
| DOC_CYCLIN_RxL_1 | 219 | 227 | PF00134 | 0.339 |
| DOC_MAPK_MEF2A_6 | 114 | 122 | PF00069 | 0.458 |
| DOC_PP1_RVXF_1 | 54 | 61 | PF00149 | 0.476 |
| DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.184 |
| DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.335 |
| DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.477 |
| DOC_WW_Pin1_4 | 39 | 44 | PF00397 | 0.396 |
| LIG_14-3-3_CanoR_1 | 55 | 61 | PF00244 | 0.384 |
| LIG_Actin_WH2_2 | 97 | 112 | PF00022 | 0.386 |
| LIG_BRCT_BRCA1_1 | 189 | 193 | PF00533 | 0.182 |
| LIG_BRCT_BRCA1_1 | 28 | 32 | PF00533 | 0.273 |
| LIG_eIF4E_1 | 99 | 105 | PF01652 | 0.389 |
| LIG_FHA_1 | 40 | 46 | PF00498 | 0.300 |
| LIG_GBD_Chelix_1 | 67 | 75 | PF00786 | 0.207 |
| LIG_KLC1_Yacidic_2 | 223 | 227 | PF13176 | 0.382 |
| LIG_LIR_Gen_1 | 135 | 144 | PF02991 | 0.387 |
| LIG_LIR_Gen_1 | 212 | 221 | PF02991 | 0.300 |
| LIG_LIR_Gen_1 | 47 | 58 | PF02991 | 0.319 |
| LIG_LIR_Gen_1 | 69 | 80 | PF02991 | 0.409 |
| LIG_LIR_Gen_1 | 96 | 105 | PF02991 | 0.347 |
| LIG_LIR_Nem_3 | 135 | 140 | PF02991 | 0.303 |
| LIG_LIR_Nem_3 | 151 | 156 | PF02991 | 0.341 |
| LIG_LIR_Nem_3 | 162 | 168 | PF02991 | 0.351 |
| LIG_LIR_Nem_3 | 212 | 216 | PF02991 | 0.296 |
| LIG_LIR_Nem_3 | 47 | 53 | PF02991 | 0.318 |
| LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.324 |
| LIG_LIR_Nem_3 | 96 | 102 | PF02991 | 0.317 |
| LIG_Pex14_1 | 74 | 78 | PF04695 | 0.439 |
| LIG_Pex14_2 | 217 | 221 | PF04695 | 0.305 |
| LIG_Pex14_2 | 93 | 97 | PF04695 | 0.349 |
| LIG_PTB_Apo_2 | 160 | 167 | PF02174 | 0.155 |
| LIG_PTB_Phospho_1 | 160 | 166 | PF10480 | 0.162 |
| LIG_Rb_pABgroove_1 | 20 | 28 | PF01858 | 0.149 |
| LIG_REV1ctd_RIR_1 | 151 | 159 | PF16727 | 0.169 |
| LIG_SH2_CRK | 213 | 217 | PF00017 | 0.204 |
| LIG_SH2_PTP2 | 133 | 136 | PF00017 | 0.438 |
| LIG_SH2_PTP2 | 72 | 75 | PF00017 | 0.444 |
| LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.343 |
| LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.334 |
| LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.355 |
| LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.299 |
| LIG_SH2_STAT5 | 225 | 228 | PF00017 | 0.456 |
| LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.306 |
| LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.346 |
| LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.321 |
| LIG_SH2_STAT5 | 99 | 102 | PF00017 | 0.309 |
| LIG_SH3_3 | 112 | 118 | PF00018 | 0.457 |
| LIG_SH3_3 | 9 | 15 | PF00018 | 0.459 |
| LIG_TRFH_1 | 142 | 146 | PF08558 | 0.184 |
| LIG_UBA3_1 | 106 | 111 | PF00899 | 0.377 |
| LIG_UBA3_1 | 216 | 222 | PF00899 | 0.300 |
| LIG_UBA3_1 | 36 | 41 | PF00899 | 0.334 |
| LIG_UBA3_1 | 49 | 56 | PF00899 | 0.300 |
| LIG_WRC_WIRS_1 | 94 | 99 | PF05994 | 0.421 |
| MOD_CK1_1 | 173 | 179 | PF00069 | 0.182 |
| MOD_CK1_1 | 198 | 204 | PF00069 | 0.191 |
| MOD_GlcNHglycan | 27 | 31 | PF01048 | 0.462 |
| MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.469 |
| MOD_GSK3_1 | 170 | 177 | PF00069 | 0.182 |
| MOD_GSK3_1 | 26 | 33 | PF00069 | 0.230 |
| MOD_NEK2_1 | 109 | 114 | PF00069 | 0.507 |
| MOD_NEK2_1 | 132 | 137 | PF00069 | 0.319 |
| MOD_NEK2_1 | 209 | 214 | PF00069 | 0.300 |
| MOD_NEK2_1 | 45 | 50 | PF00069 | 0.325 |
| MOD_NEK2_1 | 93 | 98 | PF00069 | 0.290 |
| MOD_OFUCOSY | 196 | 202 | PF10250 | 0.374 |
| MOD_PKA_2 | 109 | 115 | PF00069 | 0.400 |
| MOD_PKA_2 | 179 | 185 | PF00069 | 0.139 |
| MOD_Plk_1 | 20 | 26 | PF00069 | 0.273 |
| MOD_Plk_1 | 231 | 237 | PF00069 | 0.707 |
| MOD_Plk_2-3 | 21 | 27 | PF00069 | 0.149 |
| MOD_Plk_4 | 132 | 138 | PF00069 | 0.291 |
| MOD_Plk_4 | 148 | 154 | PF00069 | 0.325 |
| MOD_Plk_4 | 170 | 176 | PF00069 | 0.374 |
| MOD_Plk_4 | 21 | 27 | PF00069 | 0.261 |
| MOD_Plk_4 | 231 | 237 | PF00069 | 0.673 |
| MOD_Plk_4 | 45 | 51 | PF00069 | 0.227 |
| MOD_Plk_4 | 56 | 62 | PF00069 | 0.454 |
| MOD_Plk_4 | 74 | 80 | PF00069 | 0.291 |
| MOD_Plk_4 | 93 | 99 | PF00069 | 0.312 |
| MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.478 |
| MOD_ProDKin_1 | 39 | 45 | PF00069 | 0.396 |
| TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.308 |
| TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.353 |
| TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.338 |
| TRG_ENDOCYTIC_2 | 213 | 216 | PF00928 | 0.296 |
| TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.320 |
| TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.320 |
| TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.265 |
| TRG_ER_diLys_1 | 245 | 249 | PF00400 | 0.624 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5E5 | Leptomonas seymouri | 40% | 83% |
| A0A0N0P7D1 | Leptomonas seymouri | 40% | 75% |
| A0A0N0P7R2 | Leptomonas seymouri | 39% | 82% |
| A0A0N1ILQ4 | Leptomonas seymouri | 36% | 85% |
| A0A0N1PDR8 | Leptomonas seymouri | 36% | 92% |
| A0A0S4IS29 | Bodo saltans | 38% | 97% |
| A0A0S4IVS6 | Bodo saltans | 38% | 88% |
| A0A0S4IW98 | Bodo saltans | 41% | 79% |
| A0A1X0NNK7 | Trypanosomatidae | 40% | 87% |
| A0A1X0NNM4 | Trypanosomatidae | 33% | 87% |
| A0A1X0NNM5 | Trypanosomatidae | 38% | 81% |
| A0A3Q8I9T2 | Leishmania donovani | 87% | 66% |
| A0A3Q8I9X8 | Leishmania donovani | 38% | 74% |
| A0A3Q8IC05 | Leishmania donovani | 40% | 82% |
| A0A3R7KG78 | Trypanosoma rangeli | 40% | 88% |
| A0A3R7MJR2 | Trypanosoma rangeli | 33% | 89% |
| A0A3S7WSZ1 | Leishmania donovani | 39% | 83% |
| A0A3S7WT03 | Leishmania donovani | 41% | 83% |
| A0A3S7WT16 | Leishmania donovani | 34% | 77% |
| A0A422NNP1 | Trypanosoma rangeli | 35% | 83% |
| A4H7M6 | Leishmania braziliensis | 40% | 100% |
| A4H7M7 | Leishmania braziliensis | 35% | 77% |
| A4H7N0 | Leishmania braziliensis | 42% | 100% |
| A4HW12 | Leishmania infantum | 39% | 74% |
| A4HW14 | Leishmania infantum | 34% | 77% |
| A4HW15 | Leishmania infantum | 88% | 66% |
| A4HW16 | Leishmania infantum | 93% | 67% |
| A4HW18 | Leishmania infantum | 39% | 82% |
| C9ZT15 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 92% |
| C9ZT16 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 81% |
| E8NHR2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 100% | 66% |
| E9AGL0 | Leishmania infantum | 41% | 83% |
| E9AGL2 | Leishmania infantum | 39% | 83% |
| E9APR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 83% |
| E9APR4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 83% |
| E9APR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 74% |
| E9APR7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 77% |
| E9APR9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 83% |
| Q4QFQ9 | Leishmania major | 39% | 100% |
| Q4QFR2 | Leishmania major | 87% | 66% |
| Q4QFR3 | Leishmania major | 35% | 77% |
| Q4QFR5 | Leishmania major | 37% | 69% |
| Q4QFR6 | Leishmania major | 40% | 100% |
| Q9VV87 | Drosophila melanogaster | 31% | 79% |
| Q9XVQ9 | Caenorhabditis elegans | 31% | 91% |
| V5BE99 | Trypanosoma cruzi | 39% | 87% |
| V5BIX9 | Trypanosoma cruzi | 34% | 89% |
| V5BND3 | Trypanosoma cruzi | 35% | 83% |
| V5DF68 | Trypanosoma cruzi | 33% | 86% |